EyesVision Corporation logo

EyesVision Corporation (031310)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
1,007. 00
+3
+0.2988%
28.94B Market Cap
- P/E Ratio
23.06% Div Yield
69,231 Volume
- Eps
1,004
Previous Close
Add Transaction
Day Range
990 1,016
Year Range
810 2,765
Want to track 031310 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

031310 closed today higher at ₩1,007, an increase of 0.2988% from yesterday's close, completing a monthly increase of 0.3988% or ₩4. Over the past 12 months, 031310 stock lost -31.6825%.
031310 pays dividends to its shareholders, with the most recent payment made on Mar 23, 2022.
EyesVision Corporation has completed 2 stock splits, with the recent split occurring on Mar 06, 2008.
The company's stock is traded on one exchange.

031310 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

EyesVision Corporation (031310) FAQ

What is the stock price today?

The current price is ₩1,007.00.

On which exchange is it traded?

EyesVision Corporation is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 031310.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 23.06%.

What is its market cap?

As of today, the market cap is 28.94B.

Has EyesVision Corporation ever had a stock split?

EyesVision Corporation had 2 splits and the recent split was on Mar 06, 2008.

EyesVision Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
6 Mar 2008 Last Split
- IPO Date

Overview

EyesVision Corporation stands as a significant entity within the healthcare landscape, specifically targeting the innovation and production of groundbreaking ophthalmic products. This organization distinguishes itself by focusing on the development of next-generation eye care solutions, emphasizing both diagnostic and therapeutic domains. By working hand in hand with eye care professionals, clinics, and healthcare facilities, EyesVision ensures their product lineup not only meets but exceeds the current demands and standards of the industry. The foundation of their reputation is built on a solid commitment to research and development, propelling them to a leading position in the introduction of novel technologies and treatment methods that aim to improve visual health globally. Financially, EyesVision Corporation contributes notably to the sectors of healthcare and life sciences, influencing the trajectory of medical technology and patient care trends. Their dedication to innovation significantly supports worldwide efforts to enhance eye health and expand access to superior ophthalmic care.

Products and Services

  • Diagnostic Technologies

    These include a range of cutting-edge tools and equipment designed to detect and diagnose various eye conditions accurately. From advanced imaging systems to portable diagnostic devices, EyesVision Corporation provides healthcare professionals with the resources they need to assess eye health effectively, facilitating early detection and intervention strategies.

  • Therapeutic Treatments

    EyesVision offers a spectrum of treatment options that address a wide array of ocular conditions. This comprises innovative pharmaceuticals, laser therapy systems, and surgical instruments that support the management and remediation of eye diseases. By leveraging the latest in medical research and technology, EyesVision ensures patients have access to effective treatment pathways.

  • Preventative Care Solutions

    Understanding the importance of prevention in eye health, EyesVision develops solutions that support the maintenance of good visual health before the onset of diseases. These solutions include protective eyewear, nutritional supplements designed to support eye health, and educational materials that help individuals understand the importance of regular eye examinations and care.

  • Advanced Medical Interventions

    The company's line-up also extends to sophisticated medical procedures and devices aimed at tackling severe ophthalmic conditions. This includes the development of state-of-the-art microsurgical tools and the provision of next-generation therapies that offer new hope to patients with conditions that were previously deemed untreatable.

Contact Information

Address: -
Phone: -